JOHN LEVASSEUR: Open Payments
NPI 1497719538 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 31 payments from 12 companies in 2025. Trend: 2023 $1,376 · 2024 $893 · 2025 $897
Food & beverage: $707Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $190 |
| Regeneron Healthcare Solutions, Inc. | 6 | $173 |
| GENZYME CORPORATION | 5 | $161 |
| ABBVIE INC. | 6 | $121 |
| PFIZER INC. | 3 | $72 |
| Amgen Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Biocon Biologics Inc | 1 | $25 |
| Almirall LLC | 1 | $25 |
| UCB, Inc. | 1 | $24 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, OTEZLA, Yesintek, Klisyri, Bimzelx.
Industry payments across FL — which companies pay providers there.
